FDA to update labels for generic cancer drugs with signing of MODERN Labeling Act

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A new law has given FDA the authority to update the approved labeling on generics—including for many older cancer drugs.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Matthew Bin Han Ong
Matthew Bin Han Ong

Login